Discriminant validity of the Medical Outcomes Study cognitive function scale in HIV disease patients

Quality of Life Research

Volumn 7, Issue 6, 1998, Pages 551-559

  Revicki, D A ^a   Chan, K ^a   Gevirtz, F ^b  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b PCS Health Systems Incorporated   (United States)

Author keywords

Construct validity; HIV disease; MOS cognitive function scale; Psychometric characteristics

Indexed keywords

ADULT; ARTICLE; COGNITION; DEPRESSION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SELF REPORT; VALIDATION PROCESS;

ADULT; BALTIMORE; COGNITION DISORDERS; DISTRICT OF COLUMBIA; FEMALE; HIV INFECTIONS; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 0031667227     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008866122441     Document Type: Article

References (27)

1. Burgess A, Catalan J, Deyer M, Hawkins D, Gazzard B. The reliability and validity of two HIV-specific health-related quality of life measures. AIDS 1993; 7: 1001-1008.
2. Lubeck DP, Fries JF. Health status among persons infected with human immunodeficiency virus: a community-based study. Med Care 1993; 31: 269-276.
3. Lubeck DP, Fries JF. Changes in quality of life among persons with HIV infection. Qual Life Res 1992; 1: 359-366.
4. Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Rosenberger P, Fass RJ. Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS 1993; 7: 519-524.
5. Bornstein RA, Nasrallah HA, Para MF, Whitacre CC, Fass RJ. Change in neuropsychological performance in asymptomatic HIV infection: 1-year follow-up. AIDS 1993; 7: 1607-1611.
6. Egan V, Brettle RP, Goodwin GM. The Edinburgh cohort of HIV-positive drug users: pattern of cognitive impairment in relation to progression of disease. Br J Psychiatr 1992; 161: 522-531.
7. Boccellari AA, Dilly JW, Chambers DB et al. Immune function and neuropsychological performance in HIV-1-infected homosexual men. J AIDS 1993; 6: 592-601.
8. Maruff P, Currie J, Malone V, McArthur-Jackson C, Mulhall B, Benson E. Neuropsychological characterization of the AIDS dementia complex and rationalization of a test battery. Arch Neurol 1994; 51: 689-695.
9. McAllister RH, Herns MV, Harrison MJG et al. Neurological and neuropsychological performance in HIV seropositive men without symptoms. J Neurol Neurosurg Psychiatr 1992; 55: 143-148.
10. Bozzette SA, Hays RD, Berry SH, Kanouse DE. A perceived health index for use in persons with advanced HIV disease: derivation, reliability and validity. Med Care 1994; 32: 716-731.
11. Adams KM, Heaton RK. Statement concerning the NIMH neuropsychological battery. J Clin Exp Neuropsych 1990; 12: 960-962.
12. Butters N, Grant I, Haxby J et al. Assessment of AIDS-related cognitive changes: recommendations of the NIMH workshop on neuropsychological assessment approaches. J Clin Exper Neuropsychol 1990; 12: 963-978.
13. Folstein MF, Folstein SE, McHugh PR. Mini Mental State, a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
14. Power C, Selnes OA, Grim JA, McArthur JC. HIV dementia scale: a rapid screening test. AIDS 1995; 8: 273-278.
15. Jones BN, Teng EL, Folstein MF, Harrison KS. A new bedside test of cognition for patients with HIV infection. Ann Intern Med 1993; 119: 1001-1004.
16. Van Gorpet W, Miller E, Satz P, Visscher B. Neuropsychological performance in HIV-1 immunocompromised patients. Int Conf AIDS 1989; 5: 464.
17. Dilley JW, Boccellari A, Davis A. The use of the Mini Mental Status Exam as a cognitive screen in patients with AIDS. Int Conf AIDS 1989; 5: 384.
18. Wu AW, Rubin HR, Mathews WC et al. A health status questionnaire using 30 items from the Medical Outcomes Study: preliminary validation in persons with early HIV infection. Med Care 1991; 29: 786-798.
19. Stewart AL, Ware JE, Sherbourne CD, Wells KB. Psychological distress/well-being and cognitive functioning measures. In: Stewart AL, Ware JE, eds. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC: Duke University, 1992: 102-142.
20. Revicki DA, Wu AW, Murray MI. Change in clinical status, health status, and health utility outcomes in HIV-infected patients. Med Care 1995; 33: AS173-AS182.
21. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement 1977; 1: 385-401.
22. Reitan RM. Trail Making Test: Manual for Administration and Scoring. Tucson, AZ: Reitan Neuropsychology Laboratory, 1992.
23. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, The Health Institute, 1993.
24. Joseph JG, Caumartin SM, Tal M et al. Psychological functioning in a cohort of gay men at risk for AIDS: a three year descriptive study. J Nerv Mental Dis 1990; 178: 607-615.
25. Murphy JM. Psychiatric Instrument Development for Primary Care Research: Patient Self-report Questionnaires. Boston, MA: Department of Psychiatry, Harvard Medical School, 1982.
26. Mitchell JE, Marshall DW, Goethe E, Leger D, Boswell RN. Human immunodeficiency virus (HIV): immune system compromise and neuropsychological functioning. Neurology 1989; 39 (suppl): 129-133.
27. Bornstein RA, Nasrallah HA, Para MF, Fass RJ, Whitacre CC, Rice RR. Rate of CD4 decline and neuropsychological performance in HIV infection. Arch Neurol 1991; 48: 704-707.